OACC (Oaktree Acquisition III Life Sciences) Total Operating Expense: $1.21 Mil (TTM As of Mar. 2026)


OACC Oaktree Acquisition Corp III Life Sciences OACC
15 GF Score
Price $10.67
View Full Analysis

What is Oaktree Acquisition III Life Sciences Total Operating Expense?

Oaktree Acquisition III Life Sciences OACC -0.28% 15 Total Operating Expense is $1.21 Mil as of Mar. 2026. GuruFocus rates OACC with a GF Score™ of 15/100.

Oaktree Acquisition III Life Sciences's Total Operating Expense for the three months ended in Mar. 2026 was $0.46 Mil. Oaktree Acquisition III Life Sciences's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $1.21 Mil.

Oaktree Acquisition III Life Sciences Total Operating Expense Related Terms

Oaktree Acquisition III Life Sciences Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Oaktree Acquisition III Life Sciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oaktree Acquisition III Life Sciences Total Operating Expense Chart

Oaktree Acquisition III Life Sciences Annual Data
Trend Dec24 Dec25
Total Operating Expense
0.00 1.20

Oaktree Acquisition III Life Sciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial 0.45 0.27 0.23 0.26 0.46
OACC
15GF Score
Oaktree Acquisition Corp III Life Sciences OACC
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oaktree Acquisition III Life Sciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $1.21 Mil mean?
Oaktree Acquisition III Life Sciences (OACC) has a Total Operating Expense of $1.21 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Oaktree Acquisition III Life Sciences and its competitors.
Is Oaktree Acquisition III Life Sciences' Total Operating Expense too high?
Oaktree Acquisition III Life Sciences' current Total Operating Expense is $1.21 Mil. Overall, Oaktree Acquisition III Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Oaktree Acquisition III Life Sciences' Total Operating Expense compare to RAAQ and FACT?
Oaktree Acquisition III Life Sciences' Total Operating Expense of $1.21 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Diversified Financial Services company?
A good Total Operating Expense depends on the Diversified Financial Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Oaktree Acquisition III Life Sciences and its competitors. Oaktree Acquisition III Life Sciences's current Total Operating Expense is $1.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oaktree Acquisition III Life Sciences stock overvalued right now?
Oaktree Acquisition III Life Sciences (OACC) has a current Total Operating Expense of $1.21 Mil. The current Total Operating Expense is $1.21 Mil. Oaktree Acquisition III Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Oaktree Acquisition III Life Sciences (OACC), the current Total Operating Expense is $1.21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oaktree Acquisition III Life Sciences Business Description

Address 333 South Grand Avenue, 28th Floor, Los Angeles, CA, USA, 90071
Oaktree Acquisition Corp III Life Sciences is a blank check company.
15GF Score

Get the complete analysis for OACC

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.67
Price